RxDoctor Payments Data

Michael Liptay, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Chicago, ILNPI 1245338607

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.4%), education and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Covidien LP at 54.1% of the total. Reporting peaked in 2019 at $18,526 and has fallen 99.8% since, to $40 in 2024.

$40,392in general payments, 2019–2025

Across 57 payments — averaging $708.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Covidien LP$22K
  • Intuitive Surgical$10K
  • Medtronic$8K
  • Johnson & Johnson$208
  • Zimmer Biomet$139
  • Atricure, Inc.$40
  • plus $28 from 1 others
$51,136in research payments, 2019–2025

Across 10 payments — averaging $5113.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$51K

What the payments were for

  • Consulting fees$7,38818%
  • Speaking & faculty fees$20,35350%
  • Travel & lodging$2,8427%
  • Food & beverage$1,3103%
  • Education$8,50021%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Covidien LP26$21,850
Intuitive Surgical13$9,771
Medtronic13$8,357
Johnson & Johnson(2 entities)2$208
Zimmer Biomet1$139
Atricure, Inc.1$40
TEI Biosciences Inc1$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,392 in reported general payments places this provider in the 85th percentile of 220 thoracic surgery (cardiothoracic vascular surgery) providers in Illinois.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Illinois

Medicare billing

Part B allowed, 2024
$215,169
Medicare patients
424
Services billed
835

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →